Physician
Cavanaugh, Lisa
Cavanaugh, Lisa was paid $113K by Medicaid between Jan 2019 and Nov 2024, across 19 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 43% of everything it billed.
33Billing provider infoCAVANAUGH, LISA
ROSLYN HEIGHTS, NY 11577
ROSLYN HEIGHTS, NY 11577
33aNPI1619918208assigned 06/08/2006
33bProvider typePediatrics Physician
28Total paid$113K
24GClaims4,617
24DCodes billed19
24AFirst – last monthJan 2019 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#676 of 1,983
Median peer was paid$17K
This provider vs. median6.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 289 | $8K | |
| 2020 | 496 | $12K | |
| 2021 | 1,034 | $20K | |
| 2022 | 1,277 | $29K | |
| 2023 | 942 | $27K | |
| 2024incomplete | 579 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 43% | 1,038 | 904 | $49K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 352 | 318 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.1% | 551 | 501 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 383 | 353 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.9% | 908 | 812 | $7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.9% | 679 | 596 | $6K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 221 | 221 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 102 | 93 | $2K |
| 92552 | 1.2% | 66 | 66 | $1K | |
| 0071A | <1% | 14 | 14 | $901.50 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 42 | 41 | $796.04 |
| 0001A | <1% | 18 | 18 | $728.13 |
7 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.